Bio Essence Corporation (BIOE)
OTCMKTS
· Delayed Price · Currency is USD
0.2060
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT
Bio Essence Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Revenue | 0.32 | - | 0.62 | 0.89 | 0.96 | Upgrade
|
| Revenue Growth (YoY) | - | - | -30.00% | -7.38% | 16.02% | Upgrade
|
| Cost of Revenue | 0.11 | - | 0.29 | 0.59 | 0.73 | Upgrade
|
| Gross Profit | 0.22 | - | 0.33 | 0.3 | 0.23 | Upgrade
|
| Selling, General & Admin | 0.68 | 0.35 | 0.84 | 1.15 | 1.06 | Upgrade
|
| Operating Expenses | 0.68 | 0.35 | 0.84 | 1.16 | 1.06 | Upgrade
|
| Operating Income | -0.46 | -0.35 | -0.51 | -0.86 | -0.83 | Upgrade
|
| Interest Expense | -0 | -0 | -0.01 | -0.04 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.05 | -0.06 | -0 | 0.01 | 0.04 | Upgrade
|
| EBT Excluding Unusual Items | -0.51 | -0.4 | -0.53 | -0.89 | -0.84 | Upgrade
|
| Asset Writedown | -1.05 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 0.24 | 0.24 | Upgrade
|
| Pretax Income | -1.56 | -0.4 | -0.53 | -0.64 | -0.59 | Upgrade
|
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Earnings From Continuing Operations | -1.57 | -0.4 | -0.53 | -0.65 | -0.6 | Upgrade
|
| Earnings From Discontinued Operations | 0.26 | -0.57 | -0.28 | - | - | Upgrade
|
| Net Income | -1.31 | -0.97 | -0.81 | -0.65 | -0.6 | Upgrade
|
| Net Income to Common | -1.31 | -0.97 | -0.81 | -0.65 | -0.6 | Upgrade
|
| Shares Outstanding (Basic) | 38 | 34 | 33 | 33 | 33 | Upgrade
|
| Shares Outstanding (Diluted) | 38 | 34 | 33 | 33 | 33 | Upgrade
|
| Shares Change (YoY) | 11.94% | 2.86% | - | -0.08% | 0.58% | Upgrade
|
| EPS (Basic) | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 | Upgrade
|
| Free Cash Flow | 0.62 | -1.03 | -0.71 | -1.41 | -0.74 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | -0.03 | -0.02 | -0.04 | -0.02 | Upgrade
|
| Gross Margin | 67.01% | - | 52.82% | 33.60% | 23.71% | Upgrade
|
| Operating Margin | -141.83% | - | -82.23% | -96.57% | -86.84% | Upgrade
|
| Profit Margin | -404.02% | - | -130.26% | -72.92% | -62.15% | Upgrade
|
| Free Cash Flow Margin | 192.59% | - | -113.74% | -159.19% | -77.20% | Upgrade
|
| EBITDA | -0.46 | -0.34 | -0.5 | -0.82 | -0.8 | Upgrade
|
| EBITDA Margin | -141.47% | - | -79.90% | -92.54% | -83.37% | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0.01 | 0.04 | 0.03 | Upgrade
|
| EBIT | -0.46 | -0.35 | -0.51 | -0.86 | -0.83 | Upgrade
|
| EBIT Margin | -141.83% | - | -82.23% | -96.57% | -86.84% | Upgrade
|
| Revenue as Reported | 0.32 | - | 0.62 | 0.89 | 0.96 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.